Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose amoxicillin plus frequent esomeprazole for first-line Helicobacter pylori eradication
ChiCTR-IPR-15007245Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amoxicillin and esomeprazole in Helicobacter pylori infection (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoints: Helicobacter pylori eradication rate and Clarithromycin resistance. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
amoxicillinesomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR-IPR-15007245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007245.